This content is machine translated Kidney cancer Palliative systemic therapy for metastatic renal cell carcinoma Renal cell carcinoma (RCC) is the most common malignant disease of the kidney. There are currently no established predictive biomarkers to guide palliative therapy with checkpoint inhibitors (CPI), tyrosine kinase… CME-Test
View Post 14 min This content is machine translated Kidney cancer Palliative systemic therapy for metastatic renal cell carcinoma Renal cell carcinoma (RCC) is the most common malignant disease of the kidney. There are currently no established predictive biomarkers to guide palliative therapy with checkpoint inhibitors (CPI), tyrosine kinase… CME-Test
View Post 3 min This content is machine translated Renal cell carcinoma Treatment management up to date Renal cell carcinoma tends to be one of the rarer malignant tumors in adults. In terms of drug treatment options, however, this tumor entity has undergone more rapid change in…
View Post 3 min This content is machine translated Renal cell carcinoma Therapy management from the point of view of improving prognosis Renal cell carcinoma is one of the common malignant tumors of the kidney, accounts for about 3% of all tumor cases, and the rate of new cases is increasing. In…
View Post 4 min This content is machine translated Urooncology From diagnosis to therapy: Urological tumors in focus Annually, the American Society of Clinical Oncology Congress addresses the current state of research on urogenital tumors. The latest study results regarding diagnosis and therapy of prostate cancer, renal cell…
View Post 7 min This content is machine translated Renal cell carcinoma The most important studies at a glance Some exciting studies were presented on renal cell carcinoma at this year’s ASCO annual meeting. Especially for localized tumors, clinical practice may change in the near future. For the first…
View Post 6 min This content is machine translated Advanced renal cell carcinoma New points of attack under the microscope Even in the era of VEGF and checkpoint inhibitors, the prognosis for advanced renal cell carcinoma remains poor. The use of targeted therapies and immunotherapeutic approaches is difficult due to…
View Post 10 min This content is machine translated Rarer tumor entities Current therapeutic options in metastatic renal cell carcinoma. Renal cell carcinoma is one of the rather rare tumor entities. Therefore, treatment options were very limited for years and therapy was difficult. Meanwhile, tyrosine kinase inhibitors have expanded the…
View Post 2 min This content is machine translated Renal cell carcinoma Therapy with mind and system Renal cell carcinoma is one of the common malignant tumors in adults. In terms of drug treatment options, this tumor entity has undergone more rapid change in recent years than…
View Post 11 min This content is machine translated ASCO 2018 in Chicago Study news on lung, kidney and intestine KEYNOTE-042 and CARMENA: Two studies that have the potential to change practice. It’s about lung cancer – as so often lately – but also about renal cell carcinoma. Furthermore, the…
View Post 9 min This content is machine translated Renal cell carcinoma Progress in system handling Systems therapy for renal cell carcinoma is changing. Several tyrosine kinase inhibitors can significantly prolong survival in metastatic stages. Immunotherapies are also effective.
